Feature | ASTRO | October 30, 2018

Late-breaking Radiation Therapy Clinical Trials at ASTRO 2018

ASTRO 2018 Radiation Therapy Clinical Trials. #ASTRO2018 #ASTRO18 #ASTRO

October 30, 2018 — The American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting included 10 top-rated clinical studies. The ASTRO 2018 annual meeting, held Oct. 21-23 in San Antonio, Texas drews more than 11,000 attendees.

The highlighted studies below are linked to full articles. 

 

Advances in Breast and Lung Cancers

Sunday, Oct. 21

 

Advances in Genitourinary Cancers

Monday, Oct. 22

 

Advances in Oral and Oligometastatic Cancers

Tuesday, Oct. 23

 

Other ASTRO News and Videos:

Trends in Proton Therapy at ASTRO 2018 — Faster Therapy Delivery, Single-room Installs

 

SBRT Considered Safe Treatment Option for Patients With Multiple Metastases

VIDEO: Radiation Oncology Reimbursement Update From ASTRO — Interview with Anne Hubbard, MBA, ASTRO director of health policy

Hippocampal Sparing Prevents Whole-Brain Radiotherapy Cognitive Side Effects

VIDEO: Biologically Guided Radiation Therapy Using Real-time PET Imaging — Interview with Kristin Higgens, M.D., Emory 

Smart Machines To Empower Oncology Docs and Patients, Say ASTRO Experts

VIDEO: Beaumont's Experience With Proton Therapy After One Year — Interview with Peyman Kabolizadeh, M.D., Beaumont Proton Therapy Center

Biology Guided Radiotherapy May Improve Physician Confidence in Treatment of Multiple Tumors

VIDEO: The Use of Nanoparticles in Radiation Therapy — Interview with James Welsh, M.D., MD Anderson Cancer Center

Market for MRI-based RT Could Soon Widen

VIDEO: FDA-cleared Bra Helps Improve Breast Positioning During Radiation Therapy — Interview with Elizabeth Chabner-Thompson, M.D., MPH

Prostate Brachytherapy Shows Low Incidence of Short-Term Complications

VIDEO: Use of Liquid Biopsies to Assess Radiotherapy Response — Interview with Aadel Chaudhuri, M.D.

360 View of the Dedicated Radiotherapy Magnetom Sola 1.5T MRI System

VIDEO: Personalizing Radiotherapy Using Genomic Markers of Radiosensitivity — Interview with Javier Torres-Roca, M.D.

VIDEO: Improving Breast Cancer Surgery With Electronic Brachytherapy IORT —  Interview with A. M. Niser Syed, M.D.

360 View of a GE Healthcare Discovery RF Gen 2 Dedicated Radiation Therapy CT System
 

 

 

For more information: www.astro.org

Related Content

The research evaluates the feasibility of biology-guided radiotherapy to treat metastatic cancer
News | Radiation Therapy | October 24, 2020
October 24, 2020 — ...
AI-powered premium large bore CT scanner offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT) | October 24, 2020
October 24, 2020 — An estimated 1.8 million new cancer cases will be diagnosed in the U.S.
An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

Feature | CT Angiography (CTA) | October 23, 2020
October 22, 2020 – In the FORECAST randomized clinical trial, the use of ...
Be sure to register for the American Society for Radiation Oncology's (ASTRO) 62nd Annual Meeting, to be held October 24-28, 2020, via an interactive virtual platform. The meeting, Global Oncology: Radiation Therapy in a Changing World, will feature reports from the latest clinical trials; panels on global oncology, health disparities and the novel coronavirus; and an immersive attendee experience in a virtual convention center.
News | ASTRO | October 23, 2020
October 23, 2020 — Be sure to ...
This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large

This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large-scale analyses of data combined across multiple research sites, the ENIGMA Brain Injury will develop and test methods and procedures for making sense of the complexity in this data. Images courtesy of Olsen et al., Brain Imaging and Behavior, 2020

News | Magnetic Resonance Imaging (MRI) | October 23, 2020
October 23, 2020 — Trau...
IBA showcases how its Proteus solutions and its network of clinical and industrial partners are shaping the future of proton therapy
News | Proton Therapy | October 23, 2020
October 23, 2020 — IBA, a leading provider of proton thera...
RaySearch Laboratories AB will demo its latest advances in oncology software at the American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting
News | Radiation Oncology | October 23, 2020
October 23, 2020 — RaySearch will present recent and upcoming enhancements, as well as new functionality, in...
The fMRI hyperscanning environment.

(A) The fMRI hyperscanning environment. The clinician (1) and patient (2) were positioned in two different 3T MRI scanners. An audio-video link enabled online communication between the two scanners (3), and video images were used to extract frame-by-frame facial expression metrics. During simultaneous acquisition of blood oxygen level–dependent (BOLD)–fMRI data, the clinician used a button box (4) to apply electroacupuncture (EA) treatment (real/sham, double-blind) to the patient (5) to alleviate evoked pressure pain to the leg (6; Hokanson cuff inflation). Pain and affect related to the treatment were rated after each trial. (B) Study overview. After an initial behavioral visit, each individual participated in a Clinical-Interaction (hyperscan preceded by a clinical intake) and No-Interaction condition (hyperscan without a preceding intake), in a counterbalanced order, with two different partners. (C) Experimental protocol. Each hyperscan was composed of 12 repeated trials (four verum EA, four sham EA, and four no treatment) in a pseudo-randomized order. After a resting period (far left), both participants were shown a visual cue to indicate whether the next pain stimulus would be treated (green frame) or not treated (red frame) by the clinician. These cues prompted clinicians prepare to either apply or not apply treatment while evoking corresponding anticipation for the patient. Following the anticipation cue, moderately painful pressure pain was applied to the patient’s left leg, while the clinician applied or did not apply treatment, respectively. After another resting period, participants rated pain (patients), vicarious pain (clinicians), and affect (both) using a visual analog scale (VAS).

News | Clinical Trials | October 22, 2020
October 22, 2020 — The potential impact of the patient-clinician relationship on a patient's response to treatment is